| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |